Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2023 Filed Dec 7, 2023 21:01 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $19.07 | $0.00 |
DisclosureSEC source: 0001415889-23-015972 · form4-12072023_091248.xml · derivative · entry 2 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted to the Reporting Person on January 6, 2014 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:01 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionCommon Stock | 10,000 | $19.07 | $190,700.00 |
DisclosureSEC source: 0001415889-23-015972 · form4-12072023_091248.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 20:11 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock · Derivative | 57,356 | $46.15 Strike: $46.15 | $2,646,692.62 |
DisclosureSEC source: 0001415889-23-014591 · form4-10302023_081049.xml · derivative · entry 10 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,356 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This option vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date, which was August 8, 2019. Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 20:11 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock · Derivative | 2,167 | $46.15 Strike: $46.15 | $99,996.22 |
DisclosureSEC source: 0001415889-23-014591 · form4-10302023_081049.xml · derivative · entry 9 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This option vested in full on the third anniversary of the Original Grant Date, which was August 8, 2020 Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 20:11 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock | 57,356 | $46.15 | $2,646,692.62 |
DisclosureSEC source: 0001415889-23-014591 · form4-10302023_081049.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,327,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 20:11 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock | 2,167 | $46.15 | $99,996.22 |
DisclosureSEC source: 0001415889-23-014591 · form4-10302023_081049.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,270,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:26 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 4,421 | $66.96 | $296,030.16 |
DisclosureSEC source: 0001415889-23-012217 · form4-08142023_080843.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,268,388 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:23 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
Tax withholdingCommon Stock | 913 | $66.96 | $61,134.48 |
DisclosureSEC source: 0001415889-23-012215 · form4-08142023_080852.xml · nonDerivative · entry 2 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,959 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:22 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
Tax withholdingCommon Stock | 1,578 | $66.96 | $105,662.88 |
DisclosureSEC source: 0001415889-23-012212 · form4-08142023_080858.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,711 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:14 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
GrantStock Option (Right to Purchase) · Derivative | 4,154 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0001415889-23-012203 · form4-08142023_080842.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,154 Underlying: Common Stock · 4,154 shares Expires 2033-08-10 F2 · derivative.exercise_date: . The Stock Option granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:14 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
GrantCommon Stock | 4,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012203 · form4-08142023_080842.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,859 F1 · shares: 1. The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:26 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
GrantStock Option (Right to Purchase) · Derivative | 35,349 | $0.00 Strike: $72.99 | $0.00 |
DisclosureSEC source: 0001415889-23-012217 · form4-08142023_080843.xml · derivative · entry 9 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,349 Underlying: Common Stock · 35,349 shares Expires 2028-08-10 F4 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:26 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
GrantCommon Stock | 38,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012217 · form4-08142023_080843.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,272,809 F1 · shares: 1. The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:23 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
GrantStock Option (Right to Purchase) · Derivative | 11,167 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0001415889-23-012215 · form4-08142023_080852.xml · derivative · entry 3 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,167 Underlying: Common Stock · 11,167 shares Expires 2033-08-10 F3 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:23 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
GrantCommon Stock | 12,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012215 · form4-08142023_080852.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,872 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:22 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
GrantStock Option (Right to Purchase) · Derivative | 11,388 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0001415889-23-012212 · form4-08142023_080858.xml · derivative · entry 3 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,388 Underlying: Common Stock · 11,388 shares Expires 2033-08-10 F3 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:22 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
GrantCommon Stock | 12,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012212 · form4-08142023_080858.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,289 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:19 UTC |
Srega JuergenPRESIDENT CALID
|
GrantStock Option (Right to Purchase) · Derivative | 13,485 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0001415889-23-012208 · form4-08142023_080848.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · PRESIDENT CALID 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,485 Underlying: Common Stock · 13,485 shares Expires 2033-08-10 F2 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:19 UTC |
Srega JuergenPRESIDENT CALID
|
GrantCommon Stock | 14,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012208 · form4-08142023_080848.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · PRESIDENT CALID 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,695 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:17 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
GrantStock Option (Right to Purchase) · Derivative | 2,176 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0001415889-23-012206 · form4-08142023_080839.xml · derivative · entry 2 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,176 Underlying: Common Stock · 2,176 shares Expires 2033-08-10 F2 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:17 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
GrantCommon Stock | 2,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-012206 · form4-08142023_080839.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,934 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 10, 2023 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 21:14 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
Tax withholdingCommon Stock | 2,141 | $65.68 | $140,620.88 |
DisclosureSEC source: 0001415889-23-012061 · form4-08102023_090824.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,179 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 21:16 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
Tax withholdingCommon Stock | 722 | $65.68 | $47,420.96 |
DisclosureSEC source: 0001415889-23-012063 · form4-08102023_090835.xml · nonDerivative · entry 2 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,304 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 21:12 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 5,722 | $65.68 | $375,820.96 |
DisclosureSEC source: 0001415889-23-012059 · form4-08102023_090830.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,234,288 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 21:09 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 44,150 | $0.00 Strike: $47.85 | $0.00 |
DisclosureSEC source: 0001415889-23-012057 · form4-08102023_090851.xml · derivative · entry 9 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,150 shares Expires 2025-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 21:09 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 37,947 | $64.81 | $2,459,345.07 |
DisclosureSEC source: 0001415889-23-012057 · form4-08102023_090851.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,217,344 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 21:09 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock | 44,150 | $47.85 | $2,112,577.50 |
DisclosureSEC source: 0001415889-23-012057 · form4-08102023_090851.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,255,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2023 Filed Aug 10, 2023 21:14 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
Tax withholdingCommon Stock | 2,744 | $66.75 | $183,162.00 |
DisclosureSEC source: 0001415889-23-012061 · form4-08102023_090824.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,268 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 07, 2023 Filed Aug 10, 2023 21:16 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
Tax withholdingCommon Stock | 1,436 | $66.75 | $95,853.00 |
DisclosureSEC source: 0001415889-23-012063 · form4-08102023_090835.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,903 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 07, 2023 Filed Aug 10, 2023 21:12 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 9,078 | $66.75 | $605,956.50 |
DisclosureSEC source: 0001415889-23-012059 · form4-08102023_090830.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,245,803 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:10 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock · Derivative | 65,782 | $37.42 Strike: $37.42 | $2,461,562.44 |
DisclosureSEC source: 0001415889-23-011598 · form4-07312023_080714.xml · derivative · entry 10 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,782 shares Expires 2023-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date, which was August 9, 2018 Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:10 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock · Derivative | 2,672 | $37.42 Strike: $37.42 | $99,986.24 |
DisclosureSEC source: 0001415889-23-011598 · form4-07312023_080714.xml · derivative · entry 9 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,672 shares Expires 2023-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vested on the first anniversary of the Original Grant Date, which was August 9, 2018 Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:10 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock | 65,782 | $37.42 | $2,461,562.44 |
DisclosureSEC source: 0001415889-23-011598 · form4-07312023_080714.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,249,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:10 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Exercise / conversionCommon Stock | 2,672 | $37.42 | $99,986.24 |
DisclosureSEC source: 0001415889-23-011598 · form4-07312023_080714.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,183,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 20:31 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
SaleCommon Stock | 14,242 | $75.42 | $1,074,131.64 |
DisclosureSEC source: 0001415889-23-010054 · form4-06202023_080622.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,462 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00to $75.93, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:15 UTC |
Kastner Marc ADirector
|
SaleCommon Stock | 11,146 | $75.22 | $838,402.12 |
DisclosureSEC source: 0001415889-23-008489 · form4-05222023_080521.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,051 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.67, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:17 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 1,708 | $73.68 | $125,845.44 |
DisclosureSEC source: 0001415889-23-008197 · form4-05172023_080501.xml · nonDerivative · entry 4 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,180,634 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.78, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:17 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 12,917 | $73.03 | $943,328.51 |
DisclosureSEC source: 0001415889-23-008197 · form4-05172023_080501.xml · nonDerivative · entry 3 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,210,993 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.58, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:17 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 47,657 | $73.18 | $3,487,539.26 |
DisclosureSEC source: 0001415889-23-008197 · form4-05172023_080501.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,262,287 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.01 to 73.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:17 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 137,718 | $72.60 | $9,998,326.80 |
DisclosureSEC source: 0001415889-23-008197 · form4-05172023_080501.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,352,034 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $73.00, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 10,025 | $76.12 | $763,103.00 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 6 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,100,011 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.92 to $76.31, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 70,598 | $75.39 | $5,322,383.22 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 5 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,110,036 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.92 to $75.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 30,359 | $74.44 | $2,259,923.96 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 4 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,180,634 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.925 to $74.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 441 | $78.53 | $34,631.73 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 3 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,210,993 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $78.53, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 6,832 | $77.71 | $530,914.72 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,262,287 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $78.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:18 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 81,745 | $76.99 | $6,293,547.55 |
DisclosureSEC source: 0001415889-23-007734 · form4-05102023_080539.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,352,034 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.50 to $77.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2023 Filed May 4, 2023 20:11 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 16,435 | $79.21 | $1,301,816.35 |
DisclosureSEC source: 0001415889-23-007298 · form4-05042023_080551.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,352,034 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.605 to $79.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:15 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 49,476 | $78.27 | $3,872,486.52 |
DisclosureSEC source: 0001415889-23-007206 · form4-05032023_080522.xml · nonDerivative · entry 4 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,161,517 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.16 to $78.59, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:15 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 51,294 | $77.70 | $3,985,543.80 |
DisclosureSEC source: 0001415889-23-007206 · form4-05032023_080522.xml · nonDerivative · entry 3 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,210,993 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.16 to $78.155, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:15 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
SaleCommon Stock | 7,901 | $79.38 | $627,181.38 |
DisclosureSEC source: 0001415889-23-007206 · form4-05032023_080522.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,262,287 F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.31 to 79.54, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.